Research
Title : | A phase 2/3, observer-blind, randomized, controlled study to determine the safety & immunogenicity of Covishield (Covid-19 vaccine) in healthy Indian adults |
Area of Research : | Medical Sciences |
Focus Area : | Task Force (TF) |
Principal Investigator : | Ms. C. Padmapriyadarsini Director The INCLEN Trust International Delhi |
Timeline Start Year : | 2020 |
Timeline End Year : | 2021 |
Total Budget (INR): | 9,58,79,897 |
Details
Organizations involved
Implementing Agency : | The INCLEN Trust International Delhi |
Funding Agency : | Indian Council of Medical Research (ICMR) |